These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. N Engl J Med; 2005 Feb 10; 352(6):570-85. PubMed ID: 15703422 [Abstract] [Full Text] [Related]
7. Assessing the cost-effectiveness of hepatitis C screening strategies in France. Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y. J Hepatol; 2018 Oct 10; 69(4):785-792. PubMed ID: 30227916 [Abstract] [Full Text] [Related]
8. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA. Am J Gastroenterol; 2002 Mar 10; 97(3):721-8. PubMed ID: 11922569 [Abstract] [Full Text] [Related]
9. All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses. Hagan LM, Yang Z, Ehteshami M, Schinazi RF. J Viral Hepat; 2013 Dec 10; 20(12):847-57. PubMed ID: 24304454 [Abstract] [Full Text] [Related]
10. Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States. Tatar M, Keeshin SW, Mailliard M, Wilson FA. JAMA Netw Open; 2020 Sep 01; 3(9):e2015756. PubMed ID: 32880650 [Abstract] [Full Text] [Related]
14. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Veldhuijzen IK, Toy M, Hahné SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH. Gastroenterology; 2010 Feb 01; 138(2):522-30. PubMed ID: 19879275 [Abstract] [Full Text] [Related]
15. Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection. Pokorski RJ. J Insur Med; 2001 Feb 01; 33(1):12-36. PubMed ID: 11317876 [Abstract] [Full Text] [Related]
17. Projecting future complications of chronic hepatitis C in the United States. Davis GL, Albright JE, Cook SF, Rosenberg DM. Liver Transpl; 2003 Apr 01; 9(4):331-8. PubMed ID: 12682882 [Abstract] [Full Text] [Related]
18. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Jacobs RJ, Koff RS, Meyerhoff AS. Am J Gastroenterol; 2002 Feb 01; 97(2):427-34. PubMed ID: 11866283 [Abstract] [Full Text] [Related]
19. Economic model of a birth cohort screening program for hepatitis C virus. McGarry LJ, Pawar VS, Panchmatia HR, Rubin JL, Davis GL, Younossi ZM, Capretta JC, O'Grady MJ, Weinstein MC. Hepatology; 2012 May 01; 55(5):1344-55. PubMed ID: 22135116 [Abstract] [Full Text] [Related]
20. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. Kim SY, Billah K, Lieu TA, Weinstein MC. Am J Prev Med; 2006 Jun 01; 30(6):498-506. PubMed ID: 16704944 [Abstract] [Full Text] [Related] Page: [Next] [New Search]